Position in KYTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$233,130
New position
Shares Held
27,014
first reported quarter
Ownership
0.044%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MANGROVE PARTNERS IM, LLC holds $8,580,234 across 25 Biotechnology names. KYTX ranks #12 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
9,916 | $916,040 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
47,927 | $868,916 | |
| 3 | ALT |
Altimmune, Inc.
|
239,280 | $736,982 | |
| 4 | ARVN |
Arvinas, Inc.
|
69,260 | $734,156 | |
| 5 | FBRX |
Forte Biosciences, Inc.
|
25,706 | $665,785 | |
| 6 | TECH |
BIO-TECHNE Corp
|
10,243 | $535,299 | |
| 7 | RLMD |
Relmada Therapeutics, Inc.
|
71,705 | $499,066 | |
| 8 | INBX |
Inhibrx Biosciences, Inc.
|
5,531 | $371,849 |
All Filings in KYTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,130 | 27,014 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||